Pfizer completes ResApp purchase for over $115 million
Biopharmaceutical giant Pfizer has finalised its acquisition of ASX-listed digital health startup ResApp for A$179 million ($116 million), according to the University of Queensland.
Brisbane-based ResApp has developed a mobile app that analyses cough sounds and diagnoses respiratory diseases, including asthma, pneumonia, bronchiolitis, croup...
harrison.ai, Sonic Healthcare launch pathology AI joint venture
Healthcare AI startup harrison.ai and ASX-listed diagnostics provider Sonic Healthcare have set up a joint venture namedfranklin.ai.
Based on a media release, franklin.ai will develop and provide pathologists with AI-powered support tools to improve diagnosis accuracy and efficiency.
The venture will be led by harrison.ai's former...
Delphinus Medical Technologies, a Novi, Michigan-based medical imaging company, today announced the U.S. Food and Drug Administration has given its breast cancer-screening ultrasound device premarket approval.
The SoftVue 3D Whole Breast Ultrasound Tomography System is intended to be used in addition to digital mammograms to screen for breast cancer among patients with dense breast tissue....
Volpara Health, a maker of an artificial intelligence-enabled breast health platform, has added another FDA clearance to its core algorithm, the Volpara Imaging Software (VIS 3.2).
This marks the fourth clearance for Volpara’s breast health platform since its original authorization back in 2010, according to the company. The platform includes a suite of products that help with the early detection...
A new startup called Whiterabbit has emerged from stealth to announce its new CEO and the FDA clearance of its artificial intelligence-enabled breast cancer screening product.
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection, with the goal of eradicating late-stage breast cancers in the U.S. by 2025.
The WRDensity...
A breakthrough breast cancer diagnosis system could help clinicians understand the rationale behind artificial intelligence (AI) decisions.
Researchers from Charité University Hospital in Berlin, the Berlin Institute of Technology and the University of Oslo have developed the new tissue-section analysis system for diagnosing breast cancer based on AI.
The system uses heatmaps to show what...
Volpara Health, a maker of artificial intelligence breast-cancer-screening products, has acquired CRA Health, a breast cancer risk-assessment startup out of Massachusetts General Hospital.
Under the terms of the deal, Volpara will purchase all outstanding equity of CRA for $18 million, in addition to $4 million upon meeting strategic performance goals over the next year-and-a-half.
CRA’s risk...
